These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 814310)

  • 1. Some facts on drug--enzyme interactions and their relevance in discovery of new drugs.
    Ahmad SI
    J Pak Med Assoc; 1975 Jun; 25(6):136-9. PubMed ID: 814310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current trends in the therapeutic use of enzyme inhibitors in clinical practice].
    Veremeenko KN
    Vrach Delo; 1969 Nov; 11():11-9. PubMed ID: 4988514
    [No Abstract]   [Full Text] [Related]  

  • 4. [A search of new inhibitors of 5-hydroxytryptophane decarboxylase (5-HTP-D)].
    Robak J
    Folia Med Cracov; 1969; 11(1):125-55. PubMed ID: 5802128
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
    Tissot R
    Presse Med (1893); 1969 Apr; 77(17):617-8. PubMed ID: 5785080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of drugs on regulatory enzymes in metabolic pathways].
    Gumińska M
    Folia Med Cracov; 1980; 22(3-4):241-61. PubMed ID: 7026383
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drugs that act through enzymes].
    Cuparencu B
    Fiziol Norm Patol; 1969; 15(1):11-9. PubMed ID: 4238357
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors.
    Nasr G; Petit E; Vullo D; Winum JY; Supuran CT; Barboiu M
    J Med Chem; 2009 Aug; 52(15):4853-9. PubMed ID: 19580287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinson's disease: current therapeutic aspects].
    Casati C
    Clin Ter; 1971 Jan; 56(1):71-9. PubMed ID: 4944741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of monoamine oxidase inhibitors and acetylcholinesterase on the intestinal motor function].
    Pytasz M; Nagórna-Stasiak B
    Acta Physiol Pol; 1969; 20(2):319-27. PubMed ID: 5788451
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease; modern treatment.
    Tolosa E
    Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and animal experiments concerning the function of brain catecholamines.
    Matussek N
    Int Pharmacopsychiatry; 1971; 6(3):170-86. PubMed ID: 4950569
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibitor interactions with other drugs.
    Blackwell B
    J Clin Psychopharmacol; 1991 Feb; 11(1):55-9. PubMed ID: 2040717
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between calcium entry blocking drugs and carbonic anhydrase.
    Botrè C; Botrè F; Lorenti G; Pranzoni C; Scibona G
    Arzneimittelforschung; 1991 Sep; 41(9):891-4. PubMed ID: 1796915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical pharmacology of the central nervous system. 6. Specific inhibitors of enzymes implied in the synthesis of cerebral serotonin].
    Corgier M; Pacheco H
    Therapie; 1973; 28(4):639-49. PubMed ID: 4793684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.